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With a view to estimating the prevalence and resistance patterns of CA-MR-
SA in one region of Serbia, we performed an analysis of MRSA isolates from healthy 
people and hospitalised patients. The detection of CA-MRSA was carried out by 
SCCmec typing. In MRSA isolates from hospitalised patients SCCmec types IV and 
V were found in 76% of the strains. Similar percentage (80%) of CA-MRSA geno-
types was present in healthy people. SCCmec type V harbouring MRSA was the 
most successful clone. Higher prevalence of type V in hospitalised patients to that in 
healthy people (70% vs 54%) may indicate nosocomial transmissions in at least some 
hospital units. All MRSA strains from hospitalised patients were resistant to one or 
more non-β-lactam antibiotics while 52% were multi-resistant. In isolates from 
healthy people, 16% were sensitive to all non-β-lactam antibiotics and 40% were 
multi-resistant. Similar percentage of multi-resistant CA- and HA-genotypes oc-
curred in a particular environment (53% vs 50% in hospitalised patients, and 37.5% 
vs 37.5% in healthy people) indicating selective pressure of antibiotics as a leading 
force conferring antibiotic resistance. High prevalence of CA-MRSA and high re-
sistance rate both in hospitals and the community suggest that this pathogen has 
been present in the Pomoravlje Region, central Serbia for years.
Keywords: CA-MRSA, SCCmec typing, resistance patterns, healthy people, 
hospitalised patients
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is highly prevalent 
human pathogen that causes nosocomial infections worldwide. Initially, MRSA 
strains were isolated only from hospitalised patients (healthcare-associated 
 MRSA, HA-MRSA). In the last decade of the 20th century, epidemiologically 
and genetically distinct strains known as community-associated MRSA (CA-
MRSA) occurred in patients without previous contact with healthcare institu-
tions, most often in children [1]. Since then, outbreaks of CA-MRSA have been 
reported on all continents, including areas with otherwise low prevalence of 
MRSA, such as Scandinavian countries [2, 3]. A trend of increase in the number 
of MRSA infections and asymptomatic carriage has been demonstrated. Accord-
ing to the data published in 2013, the highest prevalence of MRSA in healthy 
patients across nine European countries was reported in Belgium, 2.1% [3]. 
In Asia, the rate of MRSA in all community-associated S. aureus infections 
 ranges from 2.5% to 39% [4]. The consequences of CA-MRSA infections are 
often severe, including prolonged hospitalisation and high mortality rates [1, 
5, 6].
MecA gene, which encodes PBP2a and provides the resistance to β-lactams, 
is located on the “Staphylococcal Cassette Chromosome mec” (SCCmec) genetic 
element. Most CA-MRSA strains possess SCCmec types IV or V. These elements 
are smaller than those found in HA-MRSA, and are more easily transferred 
to other strains of S. aureus [7]. SCCmec types IV and V were found in different 
genomic backgrounds [8], confi rming the apparent movement of these genetic 
elements. HA-MRSA strains may carry mecA in many types of SCCmec ele-
ments with types I, II or III as the most common ones. Apart from mecA gene and 
ccr gene that encode recombinases, SCCmec types II and III may carry genes 
located on transposons or plasmids, conferring resistance to multiple non-β- 
lactam antistaphylococcal antibiotics [9].
In recent years CA-MRSA has spread to healthcare settings and acquired 
additional antimicrobial resistance determinants under selective pressure of anti-
biotics. Changes in epidemiology made CA-MRSA recognition confusing, and 
for that reason they can be differentiated from HA-MRSA only by means of 
molecular methods. Commonly used typing techniques are pulsed-fi eld gel 
 electrophoresis (PFGE), multilocus sequence typing (MLST), typing of SCCmec 
element, spa typing, and detection of genes encoding Panton-Valentine leukoci-
din [4].
The aim of this study was to estimate the prevalence and susceptibility 
of CA-MRSA strains isolated from hospitalised patients and healthy people in 
the Pomoravlje Region of Serbia.
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Materials and Methods
Bacterial isolates
MRSA strains were isolated from nasal swabs of 50 healthy adults and 
from different clinical samples from 50 hospitalised patients in the Pomoravlje 
Region, Serbia, during the period between 2011 and 2013. The specimens were 
cultured on blood agar (bioMérieux) and incubated for 24 hours aerobically at 
37 °C. MRSA isolates were identifi ed by tube coagulase test with rabbit plasma 
(Torlak, Belgrade) and PBP2a agglutination test “Slidex MRSA Detection” (bio-
Mérieux). The identity of isolates was confi rmed by PCR for nuc gene [10] and 
mecA gene [11].
MRSA isolates were stored in dextrose broth at –20 °C, and re-cultivated 
on blood agar for further examination.
Antimicrobial susceptibility test
Antimicrobial susceptibility was determined by the automated Vitek2 sys-
tem (bioMérieux) in accordance with the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) recommendation (http://www.eucast.org). The 
Vitek2 Gram-positive susceptibility card AST-P592 was used.
Minimal inhibitory concentrations (MICs) of cefoxitin were determined 
by E test (bioMérieux, France), as per the manufacturers recommendation.
SCCmec typing
Typing of SCCmec was performed in separate PCR amplifi cations using 
the primers and PCR conditions described by Milheiriço et al. [12].
Results
MRSA rates
A total of 168 S. aureus isolates were collected from hospitalised patients. 
MRSA was identifi ed in 77 (45.8%) of them. In further investigation, 50 ran-
domised MRSA isolates were analysed.
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Among 1362 healthy adult S. aureus carriers that were neither hospitalised 
nor treated with antibiotics in the course of the previous one-year period, MRSA 
was confi rmed in 52 (3.8%) cases. Two MRSA isolates were excluded from fur-
ther study.
Susceptibility to non-β-lactam antimicrobials
MRSA strains harboured resistance to non-β-lactam antistaphylococcal 
antibiotics. All MRSA isolates from hospitalised patients were resistant to at least 
one or more antibiotics: three out of 50 isolates (6%) were resistant to only one 
antibiotic, 7 (14%) were resistant to two antibiotics, 14 (28%) to three, and re-
maining 26 (52%) were multi-resistant (resistant to more than 3 non-β-lactam 
antibiotics) (Table I). The largest number of MRSA strains were resistant to cip-
rofl oxacin (62%), erythromycin (60%), clindamycin and gentamicin (58% each), 
and tetracycline (56%).
Antimicrobial resistance of MRSA isolates from healthy people was as 
 follows: eight out of 50 isolates (16%) were sensitive to all tested non-β-lactam 
antibiotics, seven (14%) were resistant to one, six (12%) to two, nine (18%) iso-
lates were resistant to three antibiotics, and 20 isolates (40%) were multi-resistant 
(Table I). In this group, 58% of the isolates were resistant to erythromycin and 
clindamycin, 54% to gentamicin, and 52% to tetracycline.
Table I. Resistance of MRSA isolates to non-β-lactam antibiotics
No of antibiotics
Source of MRSA isolates
Hospitalised patients Healthy people
0  0  8 (16%)
1  3 (6%)  7 (14%)
2  7 (14%)  6 (12%)
3 14 (28%)  9 (18%)
≥4a 26 (52%) 20 (40%)
Total 50 (100%) 50 (100%)
aMulti-drug resistance
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SCCmec types in MRSA isolates from hospitalised and healthy people
In the group of strains isolated from hospitalised patients, patterns charac-
teristic for HA-MRSA were found in 12 (24%) out of 50 strains: seven had 
 SCCmec type I, one had type II, and four belonged to type III (Table II). In the 
remaining 38 (76%) strains SCCmec types characteristic for CA-MRSA were 
confi rmed: type IV in three (6%) strains, and type V in 35 (70%) strains.
Analysis of MRSA isolated from healthy people showed that the majority 
of SCCmec elements (80%) were of CA-MRSA types IV and V. Other SCCmec 
types were also found: type I in two strains, type II in one strain, and type III 
in fi ve strains. Two strains did not give any amplifi cation with primers used for 
SCCmec typing.
SCCmec types in multi-resistant and sensitive MRSA strains
In hospitalised patients six out of 12 MRSA isolates (50%) that contained 
SCCmec types I-III were multi-resistant, and 20 out of 38 isolates (53%) with 
 SCCmec types IV and V (Table III).
In the group of MRSA isolates from healthy people, the percentage of 
multi- resistant strains that harboured SCCmec types I–III was 37.5% (3/8). The 
same percentage (37.5% or 15/40) of multi-resistant strains possessed SCCmec 
types IV and V.
All eight isolates sensitive to tested non-β-lactam antibiotics contained 
 SCCmec type IV (fi ve isolates) or type V (three isolates).
Table II. SCCmec typing of MRSA strains from hospitalised and healthy people
Source 
of strains
SCCmec types (%)
TotalHA-MRSA types CA-MRSA types
Non-typableI II III Total
I–III
IV V Total
IV–V
Hospitalised 
patients
7
(14)
1
(2)
4
(8)
12
(24)
3
(6)
35
(70)
38
(76)
0 50
(100)
Healthy 
people
2
(4)
1
(2)
5
(10)
8
(16)
13
(26)
27
(54)
40
(80)
2
(4)
50
(100)
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Discussion
CA-MRSA appeared recently, when SCC genetic element containing mec 
gene was horizontally transferred into methicillin-sensitive S. aureus (MSSA) 
strains established in the community [13]. First CA-MRSA strains were isolated 
from persons with no previous health problems or HA-MRSA risk factors (stay 
in hospital or in a long-term care facility, kidney dialysis, antibiotic treatment, 
and so on). A few years after their appearance, CA-MRSA strains spread to hos-
pitals and other healthcare facilities. In this study, we discovered that CA-MRSA 
strains were more prevalent compared to HA-MRSA, both in healthy people 
with MRSA colonisation and in hospitalised patients. Specifi cally, we identifi ed 
CA-MRSA in 80% (vs HA-MRSA in 20%) of healthy people, and similar propor-
tions of CA- vs HA-MRSA in hospitalised patients (76% vs 24%).
CA-MRSA emerged as more virulent strains than HA-MRSA, so their 
spreading to hospital settings was expected, but the opposite direction of spread-
ing was less probable. Some authors deemed that methicillin resistance can re-
duce the virulence of HA-MRSA strains [14], as a consequence of cell wall al-
terations in MRSA strains that infl uence the Agr quorum-sensing system. The 
result is the reduction in the expression and secretion of cytolitic toxins [14]. 
According to these authors, this is the reason why some strains of HA-MRSA 
only scarcely spread across the community. On the other hand, the rate of expres-
sion of mecA gene in CA-MRSA strain is typically lower and the virulence is not 
decreased. In contrast, Queck et al. [15] found that psm gene, encoding a cytol-
ytic toxin, phenol-soluble modulin, can in some strains of MRSA be located 
 inside the SCCmec types II and III. In these strains the expression of psm gene 
is unaffected, leaving the HA-MRSA more virulent.
The fi rst detected CA-MRSA strains were commonly susceptible to non-β-
lactam antibiotics. In hospital environments, under the selective pressure of anti-
biotics, they adopted resistance genes to antistaphylococcal antibiotics. In our 
Table III. SCCmec types of multi-resistant MRSA strains from hospitalised and healthy people
Source of strains
Multi-resistant strains (%)
Total 
(%)SCCmec type
I–III IV–V
Hospitalised patients 
(n = 50)
6/12
(50)
20/38
(53)
26/50
(52)
Healthy people 
(n = 48)
3/8
(37.5)
15/40
(37.5)
18/48
(37.5)
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study, although eight CA-MRSA isolates from healthy people were susceptible 
to all tested non-β-lactam antibiotics, all other CA-MRSA isolates from healthy 
people and patients approached resistance pattern and multi-resistance of HA-
MRSA strains. In hospitalised patients, multi-resistance was present in 53% of 
CA-MRSA and 50% of HA-MRSA isolates. Slightly lower percentage of multi-
resistant strains was observed in isolates from healthy people: 37.5% multi-re-
sistant CA-MRSA and 37.5% multi-resistant HA-MRSA.
Occurrence of antibiotic-resistance determinants in bacteria, by muta-
tions or horizontal gene transfer, is associated with the decrease in their fi tness 
[16]. If fi tness cost is present, resistant and multi-resistant CA-MRSA strains will 
not be widely spread in the environments with very low or no antibiotic selective 
pressure, e.g. community environment. However, CA-MRSA strains are becom-
ing more resistant to non-β-lactam antibiotics, and at the same time the fre-
quency of CA-MRSA is increasing both in hospitals and the community. These 
facts lead to the conclusion that at least some resistance mechanisms are cost-
free. Experimental evidence confi rmed that antibiotic resistance can persist in 
bacterial population living in environments without antibiotic selective pressure, 
owing to other mechanisms: stabilisation mechanisms in which compensatory 
mutations can reduce fi tness cost without the loss of resistance, and co-selec-
tion between resistance genes and virulence genes, because of their genetic link-
age [17]. Horváth et al. [18] presented that fl uoroquinolones were marked as an 
antibiotic group associated with high fi tness cost in CA-MRSA. In our study, 
ciprofl oxacin resistant CA-MRSA from hospitalised patients was more abundant 
than sensitive strains (52% vs 26%, respectively). In the community population, 
the ratio was quite opposite: 22% ciprofl oxacin resistant strains to 58% cipro-
fl oxacin sensitive strains.
High prevalence of multi-resistant CA-MRSA in healthy people of the Po-
moravlje District, which is identical to prevalence of multi-resistant HA-MRSA 
circulating in the community, may be a consequence of the use of antibiotics 
without medical supervision. For this reason and because of intensive use of 
 antibiotics in agriculture, CA-MRSA population is exposed to antibiotic selec-
tive pressure even in natural environments. Some authors concluded that anti-
biotic concentrations far below MIC were suffi cient for selecting resistance in 
bacteria [17].
Virulence and resistance genes are not the only factors infl uencing suc-
cessful spread of pathogens. The whole genetic background contributes to epi-
demiological success. Only fi ve main MRSA clonal complexes, specifi ed by 
MLST, are present in hospitals around the world [19]. A retrospective study has 
shown that MSSA isolates from the 1960s belonged to the same clonal complexes 
as MRSA, suggesting that these genetic lineages, carrying genes contributing to 
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superior epidemicity, were present in hospitals before the acquisition of SCCmec 
element [19]. Similarly, successful clones circulating in the community are 
ST1 and ST8, mostly reported in the USA and Canada, ST80 in Europe, ST59 in 
the Asia-Pacifi c, Taiwan and Australia, and ST30 in the USA, Europe, western 
Pacifi c, Japan, and other countries worldwide [4]. The Balkan region has been 
designated as a reservoir for the ST152 clone as this type was isolated among 
 immigrants from former Yugoslavia [20]. A national surveillance study of  MRSA 
in Serbia demonstrated the presence of ST80 and ST152, but they were not preva-
lent [20].
The analysis of genetic diversity of MRSA among patients and healthcare 
workers (HCW) in a major referral hospital in Belgrade, Serbia, revealed that 
genotype CC5-MRSA-SCCmecI was predominant in patients (86.9%) [21]. CA-
MRSA genotypes were also observed, but primarily among HCW. A study was 
conducted on MRSA isolated in 2008 and 2009, when CA-MRSA had just 
 appeared in this hospital and had slowly been spreading in the environment with 
a high antibiotic selective pressure. Our study showed that a few years later in 
another part of Serbia the results were completely different. High prevalence of 
CA-MRSA and multi-resistant CA-MRSA in hospitals suggest that they have 
existed in hospitals of the Pomoravlje District for a few years. CA-MRSA 
adapted to hospital environment, acquired antibiotic resistance to non-β-lactam 
antibiotics without loss of fi tness, and became twice as abundant in hospitals as 
HA-MRSA. SCCmec type V-harbouring MRSA is the most successful clone. 
Its higher percentage (70%) in hospitals vs 54% in the community, may indicate 
clonal spread in at least some hospital units. The main external factor infl uenc-
ing this clonal spread may be inadequate hygiene measures.
Fast detection of resistance and virulence genes and rapid typing of MRSA 
are crucial for effective infection control [22]. As a result of the implementation 
of infection-preventing strategies in healthcare settings and the community in the 
USA, the incidence of invasive MRSA infections in hospitals dropped by 54% 
between 2005 and 2011 [23]. In the same period CA-MRSA infections were re-
duced by only 5%.
In conclusion, we detected high prevalence of CA-MRSA and high resist-
ance rate to non-β-lactam antistaphylococcal antibiotics, both in hospitals and 
the community, implying that this pathogen has been present in the Pomoravlje 
District, Serbia for years. CA-MRSA type V, the most frequent genotype, is sig-
nifi cantly more common in hospitalised patients than type IV, and twice more 
common in healthy people. The multi-resistance rate was similar for both types 
of MRSA (CA- or HA-) in a particular environment, indicating that selective 
pressure of antibiotics in environments is a leading force conferring antibiotic 
resistance and multi-resistance. Effective infection control measures guided by 
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genotyping results must be implemented on both sources of MRSA strains to 
prevent infections and epidemics with devastating results.
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